PZC vs. W7L, MCB, ACRL, SKIN, CRL, REVB, BAR, CBX, CLAI, and BYOT
Should you be buying PZ Cussons stock or one of its competitors? The main competitors of PZ Cussons include Warpaint London (W7L), McBride (MCB), Accrol Group (ACRL), DeepVerge plc (SKIN.L) (SKIN), Creightons (CRL), Revolution Beauty Group (REVB), Brand Architekts Group (BAR), Cellular Goods (CBX), Cel AI (CLAI), and Byotrol (BYOT). These companies are all part of the "household & personal products" industry.
PZ Cussons vs. Its Competitors
PZ Cussons (LON:PZC) and Warpaint London (LON:W7L) are both small-cap consumer defensive companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.
44.7% of PZ Cussons shares are owned by institutional investors. Comparatively, 39.8% of Warpaint London shares are owned by institutional investors. 43.7% of PZ Cussons shares are owned by company insiders. Comparatively, 41.5% of Warpaint London shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
PZ Cussons has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500. Comparatively, Warpaint London has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.
In the previous week, PZ Cussons had 4 more articles in the media than Warpaint London. MarketBeat recorded 4 mentions for PZ Cussons and 0 mentions for Warpaint London. PZ Cussons' average media sentiment score of 0.07 beat Warpaint London's score of 0.00 indicating that PZ Cussons is being referred to more favorably in the media.
PZ Cussons pays an annual dividend of GBX 4 per share and has a dividend yield of 5.4%. Warpaint London pays an annual dividend of GBX 10 per share and has a dividend yield of 2.4%. PZ Cussons pays out -29.6% of its earnings in the form of a dividend. Warpaint London pays out 44.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. PZ Cussons is clearly the better dividend stock, given its higher yield and lower payout ratio.
PZ Cussons presently has a consensus target price of GBX 110, suggesting a potential upside of 48.25%. Warpaint London has a consensus target price of GBX 680, suggesting a potential upside of 60.00%. Given Warpaint London's stronger consensus rating and higher probable upside, analysts plainly believe Warpaint London is more favorable than PZ Cussons.
Warpaint London has lower revenue, but higher earnings than PZ Cussons. PZ Cussons is trading at a lower price-to-earnings ratio than Warpaint London, indicating that it is currently the more affordable of the two stocks.
Warpaint London has a net margin of 17.35% compared to PZ Cussons' net margin of -10.80%. Warpaint London's return on equity of 35.04% beat PZ Cussons' return on equity.
Summary
Warpaint London beats PZ Cussons on 10 of the 17 factors compared between the two stocks.
Get PZ Cussons News Delivered to You Automatically
Sign up to receive the latest news and ratings for PZC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PZC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
PZ Cussons Competitors List
Related Companies and Tools
This page (LON:PZC) was last updated on 7/4/2025 by MarketBeat.com Staff